Tocilizumab in refractory rheumatoid arthritis: long-term efficacy, safety, and tolerability beyond 2 years

OBJECTIVES: To evaluate the long-term efficacy and safety of tocilizumab (TCZ) in clinical patients with rheumatoid arthritis (RA) refractory to synthetic disease-modifying antirheumatic drugs, anti-tumor necrosis factor agents, and B-cell depletion therapy with rituximab (RTX). METHODS: We conducte...

Descripción completa

Detalles Bibliográficos
Autores principales: Farah, Ziad, Ali, Sabreen, Price-Kuehne, Fiona, Mackworth-Young, Charles G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818059/
https://www.ncbi.nlm.nih.gov/pubmed/27069354
http://dx.doi.org/10.2147/BTT.S101289

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818059/
https://www.ncbi.nlm.nih.gov/pubmed/27069354
http://dx.doi.org/10.2147/BTT.S101289

Ejemplares similares